Release Date: 23/10/18 14:21 Summary: Notice of Extraordinary General Meeting/Proxy Form Price Sensitive: No Download Document 376.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%